---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-043030"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-04-09T23:59:59+00:00"
generated_at: "2026-06-04T01:01:30.908563+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Renalytix raises $1M in registered direct offering at $0.375/share, with option for up to $3.9M

## Summary
- Issued 2,666,667 ordinary shares at $0.375 each for gross proceeds of approximately $1.0 million.
- Investor has option until April 17, 2024 to purchase up to 7,811,696 additional shares at same price, potentially raising $3.9M total.
- Initial closing expected April 11, 2024; subsequent tranche closing by April 19, 2024 if option exercised.
- Offering made under effective shelf registration statement on Form S-3 (File No. 333-274733).

## SEC filing metadata
- accession: 0000950170-24-043030
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024043030/0000950170-24-043030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024043030/rnlx-20240405.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-043030
- JSON: https://secwatch.observer/filing/0000950170-24-043030.json
- Plain text: https://secwatch.observer/filing/0000950170-24-043030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.